Suchergebnisse - "Doehn, Christian"

PubPharm (6)

1

enthalten in: Aktuelle Urologie | 2021

von Rexer, H. | De Santis, M. | Doehn, C.

2

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Sternberg, C. | Donskov, F. | Haas, N. | +7

CommentIn: Clin Cancer Res. 2018 Jul 1;24(13):2979-2980. - PMID 29523625

3

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Motzer, R. | Haas, N. | Donskov, F. | +23

CommentIn: J Clin Oncol. 2017 Dec 10;35(35):3895-3897. - PMID 29068785

4

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

enthalten in: The New England journal of medicine | 2016

von Ravaud, A. | Motzer, R. | Pandha, H. | +103

CommentIn: Urology. 2017 Jul;105:13. - PMID 28089886

5

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy : results of an interim analysis of a non-interventional study

enthalten in: Onkologie | 2013

von Bergmann, L. | Goebell, P. | Kube, U. | +13

6

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy : phase III, randomised controlled trial

enthalten in: Lancet (London, England) | 2004

von Jocham, D. | Richter, A. | Hoffmann, L. | +8

CommentIn: Lancet. 2004 Feb 21;363(9409):583-4. - PMID 14987879

1
[1]